Conformational Analysis and 3D QSAR Study on Novel Partial Agonists of 5‐HT₃ Receptors

This publication has 35 references indexed in Scilit:

• Receptors for 5-Hydroxytryptamine: Current perspectives on classification and nomenclature
  Neuropharmacology, 1994
• Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-S-zacopride and [3H]granisetron
  Biochemical Pharmacology, 1993
• 5-HT3 Receptor Antagonists
  Drugs, 1991
• Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding
  British Journal of Pharmacology, 1991
• 1-(m-Chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist
  European Journal of Pharmacology, 1990
• Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study
  European Journal of Pharmacology, 1989
• Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron)
  European Journal of Pharmacology, 1989
• Pharmacological properties of GR38032F, a novel antagonist at 5‐HT₃ receptors
  British Journal of Pharmacology, 1988
• Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs
  Nature, 1985
• Conformations of some semi-rigid neuroleptic drugs. Part 1. Crystal structures of loxapine, clozapine, and HUF-2046 monohydrate {2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine, 8-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,e][1,4]diazepine, and 2-chloro-11(4-methylpiperazin-1-yl)dibenzo[b,e][1,4]diazepine monohydrate}
  Journal of the Chemical Society, Perkin Transactions 2, 1976